Studies on hepatitis C virus resistance to inhibitors in replicon systems.

about

Studies on hepatitis C virus resistance to inhibitors in replicon systems.

Item

http://www.wikidata.org/entity/Q42977247

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Studies on hepatitis C virus resistance to inhibitors in replicon systems.

@en

Studies on hepatitis C virus resistance to inhibitors in replicon systems.

@nl

type

Item

label

Studies on hepatitis C virus resistance to inhibitors in replicon systems.

@en

Studies on hepatitis C virus resistance to inhibitors in replicon systems.

@nl

prefLabel

Studies on hepatitis C virus resistance to inhibitors in replicon systems.

@en

Studies on hepatitis C virus resistance to inhibitors in replicon systems.

@nl

P1476

Studies on hepatitis C virus resistance to inhibitors in replicon systems.

@en

P2093

Mingjun Huang

http://www.w3.org/2001/XMLSchema#string

Yongsen Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

In Vitro Selection and Characterization of Hepatitis C Virus Serine Protease Variants Resistant to an Active-Site Peptide Inhibitor

Selection of Replicon Variants Resistant to ACH-806, a Novel Hepatitis C Virus Inhibitor with No Cross-Resistance to NS3 Protease and NS5B Polymerase Inhibitors

GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease.

Antiviral resistance and specifically targeted therapy for HCV (STAT-C).

In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms.

Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase.

Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.

P304

Unit 13B.2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/0471141755.PH13B02S50

http://www.w3.org/2001/XMLSchema#string

P478

Chapter 13

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22294367

http://www.w3.org/2001/XMLSchema#string